665.4500 7.50 (1.14%)
NSE Sep 19, 2025 15:31 PM
Volume: 505.8K
 

665.45
1.14%
Angel Broking
Unique investment opportunity in drug research business: While almost all Indian pharma companies are in generic drugs business, Syngene supports its clients to invent new drugs. It has 8 of the top 10 global pharma companies as its clients and also has long term contracts with some big pharma companies. In our view Syngene provides a uni..
Syngene International Ltd. is trading below its 150 day SMA of 667.1
More from Syngene International Ltd.
Recommended